Posted in | News | Nanomedicine | Nanomaterials

NanoViricides Present Lecture on Nanomedicine at International Conference on Nano-Materials and Applications

NanoViricides, Inc. (OTC BB: NNVC.OB), said that Anil R. Diwan, Ph.D., Company President, was invited to present a lecture on nanomedicines and nanoviricides at the International Conference on Nano-Materials and Applications (ICNAMA-2008) held by Shivaji University, Kolhapur, India (SUK).

"We are entering an exciting era in medicine. Nanomedicine promises to provide medicines and diagnostics with effectiveness that earlier could only have been imagined. Previously incurable diseases such as cancer and HIV/AIDS may now be tackled effectively," he said, adding "A clear triumph of nanoviricide materials design and science is now evident. We have been able to develop both safe and highly effective drug candidates against many viral diseases. For example, for HIV/AIDS, NanoViricides, Inc. may now have a functional cure (as recently defined by Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases)." He also talked about the highly effective bird flu and influenza treatments being developed by the Company.

Dr. Diwan was also the Chief Guest of the Valedictory Ceremonies. In his speech at the closing ceremonies, he urged the participants that, "interdisciplinary cooperation is essential in the field of nanotechnology. Science and technology from diverse disciplines such as Physics, Chemistry, Electronics, Materials Science, as well as Biotechnology, Pharmacy, and Medicine need to come together if we are to realize the full potential of nanotechnology. The vast untapped talent of rural India should benefit from the exposure they have been fortunate to receive at this conference."

Professor A.A. Dange, Director of the Board of College and University Development, SUK, said he was pleased to have Dr. Diwan as the guest and hopes that the University can work together with him for development of the nanomedicine field in India. Professor M.M. Salunkhe, Vice-Chancellor, SUK, opened the Conference, commenting that he was very excited to bring this opportunity to expose rural Indian scientists from all over India to the highly specialized nanomaterials work being done at highly recognized Institutes and Companies in India as well as abroad.

The International Conference was organized jointly by the Departments of Chemistry and Physics of SUK, from Dec. 9th to Dec. 11th, and was attended by delegates from the USA, UK, Japan, France, Israel, the Netherlands, South Korea, Taiwan, Singapore, and Thailand, among other countries.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    NanoViricides, Inc. (2019, February 15). NanoViricides Present Lecture on Nanomedicine at International Conference on Nano-Materials and Applications. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=9175.

  • MLA

    NanoViricides, Inc. "NanoViricides Present Lecture on Nanomedicine at International Conference on Nano-Materials and Applications". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=9175>.

  • Chicago

    NanoViricides, Inc. "NanoViricides Present Lecture on Nanomedicine at International Conference on Nano-Materials and Applications". AZoNano. https://www.azonano.com/news.aspx?newsID=9175. (accessed November 21, 2024).

  • Harvard

    NanoViricides, Inc. 2019. NanoViricides Present Lecture on Nanomedicine at International Conference on Nano-Materials and Applications. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=9175.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.